Literature DB >> 19013881

Upper limb lymphedema 27 (ULL27): Dutch translation and validation of an illness-specific health-related quality of life questionnaire for patients with upper limb lymphedema.

P B Viehoff1, F R van Genderen, H Wittink.   

Abstract

The health-related quality of life questionnaire for lymphedema of the upper limb (ULL27) was translated into Dutch according to international guidelines and validated. Eighty-four patients with lymphedema that occurred after axillary surgery for breast cancer and subsequent radiotherapy, chemotherapy, or hormonal therapy, completed the translated version of the ULL27 and the RAND36. Severity of upper limb edema was measured by specialized physiotherapists. The internal consistency of the domains of the questionnaire was good as were the convergent validity and discriminant ability. Upper limb volume and the domains of the ULL27 were not correlated. The Dutch translation of the ULL27 questionnaire has good internal consistency and validity but further research is needed to determine its responsiveness.

Entities:  

Mesh:

Year:  2008        PMID: 19013881

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  13 in total

1.  Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema.

Authors:  Yeşim Bakar; Alper Tuğral; Özlem Özdemir; Elif Duygu; Ümmügül Üyetürk
Journal:  Eur J Breast Health       Date:  2017-07-01

2.  Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.

Authors:  Hoda E Sayegh; Maria S Asdourian; Meyha N Swaroop; Cheryl L Brunelle; Melissa N Skolny; Laura Salama; Alphonse G Taghian
Journal:  Curr Breast Cancer Rep       Date:  2017-05-03

3.  The reliability and validity of Lymphedema Quality of Life Questionnaire-Arm in Turkish patients with upper limb lymphedema related with breast cancer.

Authors:  Pınar Borman; Ayşegül Yaman; Merve Denizli; Sevilay Karahan; Oya Özdemir
Journal:  Turk J Phys Med Rehabil       Date:  2018-07-09

Review 4.  A methodological review of the Short Form Health Survey 36 (SF-36) and its derivatives among breast cancer survivors.

Authors:  Charlene Treanor; Michael Donnelly
Journal:  Qual Life Res       Date:  2014-08-20       Impact factor: 4.147

5.  Lymphoedema functioning, disability and health questionnaire Turkish version: translation, cross-cultural adaptation and validation.

Authors:  Alis Kostanoglu; Zeynep Hosbay; Ela Tarakci
Journal:  J Phys Ther Sci       Date:  2016-06-28

6.  Psychometric evaluation of the Persian version of the Lymphedema Life Impact Scale (LLIS, version 1) in breast cancer patients.

Authors:  Shahpar Haghighat; Ali Montazeri; Farid Zayeri; Mandana Ebrahimi; Jan Weiss
Journal:  Health Qual Life Outcomes       Date:  2018-06-28       Impact factor: 3.186

7.  Open Trial of Vitamin B12 Nasal Drops in Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Comparison of Responders and Non-Responders.

Authors:  C Linda Mc van Campen; Klaas Riepma; Frans C Visser
Journal:  Front Pharmacol       Date:  2019-09-20       Impact factor: 5.810

8.  The Reliability and Validity of Quality of Life Questionnaire Upper Limb Lymphedema (ULL-27) Turkish Patient With Breast Cancer Related Lymphedema.

Authors:  Ayşe Kayali Vatansever; Tuğba Yavuzşen; Didem Karadibak
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

Review 9.  Patient-Reported Outcome Measures in Lymphedema: A Systematic Review and COSMIN Analysis.

Authors:  Louise Marie Beelen; Anne-Margreet van Dishoeck; Elena Tsangaris; Michelle Coriddi; Joseph H Dayan; Andrea L Pusic; Anne Klassen; Dalibor Vasilic
Journal:  Ann Surg Oncol       Date:  2020-11-28       Impact factor: 5.344

10.  Physical activity measures in patients with myalgic encephalomyelitis/chronic fatigue syndrome: correlations between peak oxygen consumption, the physical functioning scale of the SF-36 questionnaire, and the number of steps from an activity meter.

Authors:  C M C van Campen; Peter C Rowe; Freek W A Verheugt; Frans C Visser
Journal:  J Transl Med       Date:  2020-06-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.